IDEAYA Biosciences, Inc. (IDYA) Stock price, Description, News & Info

#Thinksabio latest news

$IDYA – IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma